Hadassah

Orthopedic Trauma Turns Tragedy into Innovation at Hadassah

Thursday, Nov 20 2014

Terrorism and other mass casualty events have been the mother of invention for the Hadassah Medical Organization’s orthopedic trauma teams.

With each mass casualty event, its specialists innovate and learn from the experience, crafting more effective treatment techniques and protocols for treating victims of orthopedic trauma. At the same time, Hadassah continues to pioneer a groundbreaking stem cell treatment— using the stem cells from a patient’s own bone marrow— to heal complex fractures faster and more successfully. Combining stem cells and growth factors to regenerate bone, Hadassah is also trailblazing a biological solution to severe bone loss.

Most recently, Prof. Rami Mosheiff, head of Orthopedic Trauma at Hadassah, achieved a patent for a “Mesenchymal Stem Cells Delivery System, Intended for Bone” and a “Tissue Regeneration Membrane,” with which he begins clinical trials in the near future. This Regenecure “Regenerative Membrane Implant” was invented by Prof. Mosheiff, along with Prof. Michael Friedman, a biomaterials expert at the Hebrew University School of Pharmacy. The expectation is that the implant will accelerate healing of severe fractures by 40 percent, with a single-stage procedure that just requires a minor modification to traditional surgical practice. The intent is for it also to be a stand-alone device, as well as used in conjunction with bone grafts.

The upcoming clinical trial will evaluate the safety and efficacy of the implant as a bone- stimulating aid for orthopedic trauma cases. Participants will be male and female patients who have sustained a fracture of their femur bone, where there is an increased risk of the bone not fusing successfully. While one of the trials will be at Hadassah, multi-center trials will also be initiated.

Hadassah is proud of the diversity of its staff and its patients, reflecting what peace would look like in the Middle East. Prof. Mosheiff recounts the story of a Palestinian boy who stepped on a landmine and suffered serious injuries to both his legs. Although Hadassah’s surgeons had to amputate his left leg, they were able to use tissue from the amputated leg to repair the badly torn up right one.

Eager to get his son home, Prof. Mosheiff relates, the father took the boy out of the hospital before doctors could provide him with a prosthesis. Not long afterwards, former Israeli President Ezer Weizman underwent some surgery at Hadassah and King Hussein of Jordan came to visit him.

When the monarch asked if there was anything he could do for Hadassah, Mosheiff says, “we asked him to find this boy.” King Hussein did so, and the young man was brought back to the hospital to be fitted with the artificial leg.

“I still believe, more than ever,” Prof. Mosheiff notes, “that medicine is a bridge to peace.”

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Nov 30 2016

Hadassah Teams Up with Spinal Cord Institute to Study Outcomes of Traumatic Injuries

The medical interventions and outcomes for Israelis with a spinal cord injury (SCI) will now be captured in the Rick Hansen SCI Registry (RHSCIR), thanks to the November 16th launch of a partnership between the Hadassah Medical Organization and the Rick Hansen Institute (RHI), a Canadian-based not-for-profit organization named after the paralympic athlete who suffered a severe spinal cord injury following a car accident.

READ MORE ›
alt_text

Thursday, Nov 17 2016

A Birthday Party in Hadassah’s PICU: Helping a Four-Year-Old Recover

Yehoshua "Shuki" Pepper was crossing a Jerusalem street with an older sibling when a car ran him over. He was rushed to Hadassah Hospital Ein Kerem's Pediatric Intensive Care Unit in fair condition, but he wasn't speaking and subsequent MRIs of his head injury were worrisome.

READ MORE ›
alt_text

Thursday, Nov 17 2016

Ethiopian Pre-Nursing Students: On the Way to Fulfilling a Dream

“I know that some people are fine with looking at a screen all day, but I know I need the human touch--to work with people. I want to be a nurse, " relates Sarah Talala, one of the 18 students of Ethiopian background who were given the opportunity to take a course which enabled them to advance to pre-academic studies at the Hebrew University and then on to nursing school at the Hadassah-Hebrew University Henrietta Szold School of Nursing.

READ MORE ›
alt_text

Monday, Nov 14 2016

Granalix BioTechnologies Introduces Food Additive to Protect Against Neurodegenerative Disease

Granalix BioTechnologies, whose founder and Chief Executive Officer is Hadassah Medical Organization Experimental Neurologist Prof. Ruth Gabizon, has launched a food supplement containing pomegranate oil that has proven to protect against neurodegenerative diseases in pre-clinical models.

READ MORE ›

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Membership Questions

membership@hadassah.org

(800) 664-5646

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Missions Department

missions@hadassah.org

(800) 237-1517

Show More